« Back
Home /
Vilobelimab Biosimilar（Anti-Complement C5 Reference Antibody）

Vilobelimab Biosimilar（Anti-Complement C5 Reference Antibody）

Item no.	DCC-A834-100mg
Manufacturer	DCChemicals
CASRN	2250440-41-4
Amount	100 mg
Category	Neuroscience Neuroinflammation
Specific against	other
Available
Manufacturer - Applications	Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer